Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
28.36
+0.03 (0.10%)
Jun 4, 2025, 12:25 PM - Market open
Fresenius Medical Care AG Employees
Fresenius Medical Care AG had 111,513 employees as of December 31, 2024. The number of employees decreased by 8,332 or -6.95% compared to the previous year.
Employees
111,513
Change (1Y)
-8,332
Growth (1Y)
-6.95%
Revenue / Employee
$188,936
Profits / Employee
$5,992
Market Cap
16.71B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 111,513 | -8,332 | -6.95% |
Dec 31, 2023 | 119,845 | -8,199 | -6.40% |
Dec 31, 2022 | 128,044 | 5,135 | 4.18% |
Dec 31, 2021 | 122,909 | -2,455 | -1.96% |
Dec 31, 2020 | 125,364 | 4,705 | 3.90% |
Dec 31, 2019 | 120,659 | 8,001 | 7.10% |
Dec 31, 2018 | 112,658 | -1,342 | -1.18% |
Dec 31, 2017 | 114,000 | 4,681 | 4.28% |
Dec 31, 2016 | 109,319 | 5,286 | 5.08% |
Dec 31, 2015 | 104,033 | 4,138 | 4.14% |
Dec 31, 2014 | 99,895 | 9,205 | 10.15% |
Dec 31, 2013 | 90,690 | 4,537 | 5.27% |
Dec 31, 2012 | 86,153 | 6,994 | 8.84% |
Dec 31, 2011 | 79,159 | 5,707 | 7.77% |
Dec 31, 2010 | 73,452 | 5,464 | 8.04% |
Dec 31, 2009 | 67,988 | 3,322 | 5.14% |
Dec 31, 2008 | 64,666 | 3,260 | 5.31% |
Dec 31, 2007 | 61,406 | 4,603 | 8.10% |
Dec 31, 2006 | 56,803 | 9,282 | 19.53% |
Dec 31, 2005 | 47,521 | 2,995 | 6.73% |
Dec 31, 2004 | 44,526 | 3,429 | 8.34% |
Dec 31, 2003 | 41,097 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
FMS News
- 4 hours ago - Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S. - PRNewsWire
- 5 days ago - Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025 - PRNewsWire
- 13 days ago - Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History - PRNewsWire
- 27 days ago - Fresenius Medical Care AG (FMS) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 4 weeks ago - Fresenius Medical Care starts 2025 with strong organic revenue and income growth - PRNewsWire
- 4 weeks ago - Fresenius Medical Care tops market expectations in 1st quarter - Reuters
- 2 months ago - Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum - PRNewsWire
- 3 months ago - Fresenius Medical Care's stock falls on Fresenius' stake sale - Reuters